Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019
- PMID: 32818146
- PMCID: PMC7423294
- DOI: 10.1093/ofid/ofaa315
Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019
Abstract
Utilizing 34 348 severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) nucleic acid amplification test (NAAT) results from 2 health systems, we estimated the clinical sensitivity of a single SARS-CoV-2 NAAT. We found that SARS-CoV-2 NAAT has 82%-97% sensitivity for diagnosing coronavirus disease 2019 among symptomatic patients.
Keywords: COVID-19; SARS-CoV-2.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures
Similar articles
-
Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.Open Forum Infect Dis. 2020 Nov 24;8(1):ofaa559. doi: 10.1093/ofid/ofaa559. eCollection 2021 Jan. Open Forum Infect Dis. 2020. PMID: 34164560 Free PMC article. Review.
-
Pre-endoscopy coronavirus disease 2019 screening and severe acute respiratory syndrome coronavirus-2 nucleic acid amplification testing in the Veterans Affairs healthcare system: clinical practice patterns, outcomes, and relationship to procedure volume.Gastrointest Endosc. 2022 Sep;96(3):423-432.e7. doi: 10.1016/j.gie.2022.04.018. Epub 2022 Apr 22. Gastrointest Endosc. 2022. PMID: 35461889 Free PMC article.
-
Indications for SARS-CoV-2 nucleic acid amplification test for areas with low endemicity.J Infect Chemother. 2022 Feb;28(2):238-241. doi: 10.1016/j.jiac.2021.10.029. Epub 2021 Nov 9. J Infect Chemother. 2022. PMID: 34776347 Free PMC article.
-
Cardiogenic Shock Caused by SARS-CoV-2 in a Patient with Serial Negative Nucleic Acid Amplification Tests. Case Report.SN Compr Clin Med. 2020;2(10):1903-1905. doi: 10.1007/s42399-020-00496-6. Epub 2020 Aug 31. SN Compr Clin Med. 2020. PMID: 32904594 Free PMC article.
-
Microbiological Testing for Coronavirus Disease 2019.JMA J. 2021 Apr 15;4(2):67-75. doi: 10.31662/jmaj.2021-0012. Epub 2021 Apr 2. JMA J. 2021. PMID: 33997438 Free PMC article. Review.
Cited by
-
Diagnostic sensitivity of RT-PCR assays on nasopharyngeal specimens for detection of SARS-CoV-2 infection: A Systematic Review and Meta-Analysis.Caspian J Intern Med. 2022;13(Suppl 3):139-147. doi: 10.22088/cjim.13.0.139. Caspian J Intern Med. 2022. PMID: 35872685 Free PMC article. Review.
-
Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.Open Forum Infect Dis. 2020 Nov 24;8(1):ofaa559. doi: 10.1093/ofid/ofaa559. eCollection 2021 Jan. Open Forum Infect Dis. 2020. PMID: 34164560 Free PMC article. Review.
-
Sensitivity of the Molecular Test in Saliva for Detection of COVID-19 in Pediatric Patients With Concurrent Conditions.Front Pediatr. 2021 Apr 12;9:642781. doi: 10.3389/fped.2021.642781. eCollection 2021. Front Pediatr. 2021. PMID: 33912522 Free PMC article.
-
Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.JAMA Netw Open. 2022 Oct 3;5(10):e2236288. doi: 10.1001/jamanetworkopen.2022.36288. JAMA Netw Open. 2022. PMID: 36223119 Free PMC article.
-
Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads.J Clin Virol. 2021 Jul;140:104843. doi: 10.1016/j.jcv.2021.104843. Epub 2021 Apr 24. J Clin Virol. 2021. PMID: 33979738 Free PMC article. No abstract available.
References
-
- Food and Drug Administration. Policy for Diagnostics Testing in Laboratories Certified to Perform High-Complexity Testing under Clinical Laboratory Improvement Amendments (CLIA) prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency. Vol. 85: Washington, DC: Federal; Register: pp 13169–70.
-
- Saah AJ, Hoover DR. “Sensitivity” and “specificity” reconsidered: the meaning of these terms in analytical and diagnostic settings. Ann Intern Med 1997; 126:91–4. - PubMed
-
- Basu A, Zinger T, Inglima K, et al. . Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution. J Clin Microbiol 2020; 58(8):e01136–20. doi: 10.1128/JCM.01136-20 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous